Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Anticancer Research|March 29, 2022
Oncogenic Fusions in Gliomas: An Institutional ExperienceJiri Polivka, Marian Svajdler, Vladimir Priban, et al.
Anticancer Research|January 25, 2023
Preoperative Plasma miRNA Levels Predict Prognosis in Early-stage Malignant MelanomaMahyar Sharif Bagheri, Jiri Polivka, Inka Treskova, et al.
Anticancer Research|December 1, 2017
Predictive Significance of Thymidylate Synthase Expression in Non-small Cell Lung CancerVlastimil Kulda, Kristyna Hrda, Zbynek Houdek, et al.
Anticancer Research|April 22, 2011
Evaluation of tumour markers as differential diagnostic tool in patients with suspicion of liver metastases from breast cancerVaclav Liska, Lubos Holubec, Vladislav Treska, et al.
Anticancer Research|September 3, 2021
BAI1 as a Prognostic Marker of Clear Cell Renal Cell Carcinoma (ccRCC)Martin Pesta, Ivan Travnicek, Vlastimil Kulda, et al.
The EPMA Journal|November 23, 2022
Ischemic stroke of unclear aetiology: a case-by-case analysis and call for a multi-professional predictive, preventive and personalised approachOlga Golubnitschaja, Pavel Potuznik, Jiri Polivka, et al.
Cancer Genomics & Proteomics|July 3, 2023
Next Generation Sequencing Analysis and its Benefit for Targeted Therapy of Lung AdenocarcinomaVlastimil Kulda, Jiri Polivka, Martin Svaton, et al.
Anticancer Research|November 24, 2011
Prognostic significance of TIMP-1 in non-small cell lung cancerMartin Pesta, Vlastimil Kulda, Radek Kucera, et al.
Casopis Lekaru Ceskych|April 21, 2012
[Morphology and etiopathogenesis of the abdominal aortic aneurysm]Lada Eberlová, Zbynek Tonar, Vera Krízková, et al.
Cancer Medicine|October 10, 2024
Predictive Significance of Combined Plasmatic Detection of BRAF Mutations and S100B Tumor Marker in Early-Stage Malignant MelanomaJiri Polivka, Mohamed A Gouda, Mahyar Sharif, et al.
Pageof 6